Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomi...
PURPOSE To present primary and final analyses from the randomized, double-blind, placebo-controlled, phase III iNTEGRATE study, which evaluated the safety and efficacy of ibrutinib with prednisone in...